Sorrento Therapeutics

(OTC) SRNE

Current Price$0.00

Market Cap$385.90K

Since IPO (2009)-100%

5 Year-100%

1 Year-71%

1 Month-22%

Sorrento Therapeutics Financials at a Glance

Market Cap

$385.90K

Revenue (TTM)

$64.27M

Net Income (TTM)

-$549.21M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.24 (Low)

Dividend

$0.00

Beta (Volatility)

-0.24 (Low)

Price

$0.00

Volume

130

Open

$0.00

Price

$0.00

Volume

130

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

May 29, 2026

Dividend

$0.00

Beta (Volatility)

-0.24 (Low)

Price

$0.00

Volume

130

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

May 29, 2026

SRNE News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sorrento Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

949

CEO

Henry H. Ji, PhD

Website

www.sorrentotherapeutics.com

Headquarters

San Diego, CA 92121, US

SRNE Financials

Key Financial Metrics (TTM)

Gross Margin

46.77%

Operating Margin

-802.55%

Net Income Margin

-911.60%

Return on Equity

-1904.94%

Return on Capital

-435.13%

Return on Assets

-121.15%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$385.90K

Shares Outstanding

551.28M

Volume

130

Avg. Volume

253.44K

Financials (TTM)

Gross Profit

$28.64M

Operating Income

-$463.35M

EBITDA

-$527.87M

Operating Cash Flow

-$234.63M

Capital Expenditure

-$8.59M

Free Cash Flow

-$243.21M

Cash & ST Invst.

$80.64M

Total Debt

$207.60M

Sorrento Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2023YOY CHG

Revenue

$15.03M

+31.1%

Gross Profit

$6.57M

+14.2%

Gross Margin

43.74%

N/A

Market Cap

$385.90K

N/A

Market Cap/Employee

$406.64

N/A

Employees

949

N/A

Net Income

-$95.21M

+56.6%

EBITDA

-$99.48M

+53.5%

Quarterly Fundamentals

Name

Q2 2023YOY CHG

Total Cash

$80.64M

-39.6%

Total Debt

$207.60M

-4.8%

Accounts Receivable

$32.73M

+32.4%

Inventory

$9.65M

-53.4%

Long Term Debt

$74.19M

-55.7%

Short Term Debt

$133.41M

+163.0%

Return on Assets

-1.21%

N/A

Return on Invested Capital

-3.48%

N/A

Free Cash Flow

-$55.80M

+33.3%

Operating Cash Flow

-$55.66M

+31.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FAMDFFutura Medical plc

FAMDFFutura Medical plc$0.00+0.00%

FNAMEvolutionary Genomics, Inc.

FNAMEvolutionary Genomics, Inc.$0.00+0.00%

CLABFCore One Labs Inc.

CLABFCore One Labs Inc.$0.00+0.00%

ENSCEnsysce Biosciences, Inc.

ENSCEnsysce Biosciences, Inc.$0.26-5.66%

KNBIFKane Biotech Inc.

KNBIFKane Biotech Inc.$0.02+0.00%

TXTMProText Mobility, Inc.

TXTMProText Mobility, Inc.$0.00+0.00%

ENZNViskase Companies, Inc.

ENZNViskase Companies, Inc.$4.25+1.07%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.74-0.03%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$36.06+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.33+0.00%

ERICTelefonaktiebolaget Lm Ericsson (publ)

ERICTelefonaktiebolaget Lm Ericsson (publ)$10.33-0.12%

MARAMara Holdings

MARAMara Holdings$12.08-0.01%

CLSKCleanSpark

CLSKCleanSpark$13.25+0.07%

NOKNokia

NOKNokia$11.76+0.01%

Questions About SRNE

What is the current price of Sorrento Therapeutics?

Sorrento Therapeutics is trading at $0.00 per share.

What is the 52-week range for Sorrento Therapeutics?

Over the past 52 weeks, Sorrento Therapeutics has traded between $0.00 and $0.10.

How much debt does Sorrento Therapeutics have?

As of the most recent reporting period, Sorrento Therapeutics reported total debt of $134.50M.

How much cash does Sorrento Therapeutics have on hand?

Sorrento Therapeutics reported $23.63M in cash and cash equivalents in its most recent financial results.

What is Sorrento Therapeutics’s dividend yield?

Sorrento Therapeutics does not currently have a dividend yield.

Sorrento Therapeutics

Sorrento Therapeutics Financials at a Glance

SRNE News

Why Sorrento Therapeutics Stock Crashed Today

Why Shares of Sorrento Therapeutics Are Up Today

Why Sorrento Therapeutics Stock Is Crashing Today

Why Sorrento Therapeutics Stock Is on the Rise Today

Why Sorrento Therapeutics' Shares Tumbled 23.4% in September

Why Sorrento Therapeutics Stock Is Marching Higher Today

2 Penny Stocks That Could Make You Filthy Rich

Why Sorrento Therapeutics Stock Is Popping Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sorrento Therapeutics

SRNE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sorrento Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SRNE

What is the current price of Sorrento Therapeutics?

What is the 52-week range for Sorrento Therapeutics?

How much debt does Sorrento Therapeutics have?

How much cash does Sorrento Therapeutics have on hand?

What is Sorrento Therapeutics’s dividend yield?

Premium Investing Services